The US Supreme Court has come down to hear a challenge to the Federal laws in Ratluanaanaanay that bring four cannabis companies, including many operators of infants.
Rejection by the highest court The provisions of canna et al v. Bondi They are closely watching the care of the White House and President Donald Trump has the desire of Themp in Marchuana who has redeemed again as the main hope of the lower legal of the law of the law.
Josh Schiller, a partner at Bot Fair Firm Boies Schiller and one of the attorneys representing Miracles, did not immediately respond to a request for comment.
A spokesperson for Verano Holding Corp.
Marijuana’s domestic Supreme Court failed
In addition to verano, litters were suppliers of canna, massachusetts merchant; Gyasi Traders, CEO of Trevit delivery service; And a smart farm, farmer.
The judgments of the Supreme Court met behind closed doors on December 12 to look at the requests of Cannabis companies, brought after the court of massachusetts and the court of application rejected their constitutional challenge.
Companies hope to bring cannabis laws before the Supreme Court as early as 2005.
They have argued the most controversial situations since then, with more than two states using marijuana for adults, that the true basis of the decision Gonzales vs. raich it no longer works.
Their transfer referred and commented on different cases in 2021 from the Supreme Court Justice Clalence Tlamence Thomas, who proposed the law “appropriate.”
In their disclosure, the companies argued that:
- The US Constitution gives them “the right to cultivate and be able to supply Marijuana” which is deeply rooted in the nation’s history and its legal traditions. “
- The Controlled Substances Act violates the Fifth Amendment right to due process.
The Trump White House is now optimistic about cannabis reform
Schiller, one of the lawyers, was previously told Mjbizdaily That this case was an attempt to “shake the box a little” after efforts to reform the Marijuana were organized in Congress and elsewhere.
Notably, the companies filed their first lawsuit a few months after the Biden-Era Marchuanu reimbursement process resulted in a controversial declaration from health regulators that cannabis has a “currently accepted” medical use in the United States.
That led to a proposal by the justice department to downgrade marijuana to a Schedule 3 drug — a proposal that ultimately prompted Trump’s inauguration.
But now, the White House is said to be considering ordering regulatory agencies to reclassify marijuana and prescribe certain CBD treatments to be covered by Medicare.
Subscribe to MJBIZ TRCROCK
Exclusive industry data and analysis to help you make informed business decisions and prevent costly missteps. All facts, no hype.
What you will get:
- Monthly and quarterly updates, with new data and insights
- Financial Forecasts + Financial Investment Trends
- A state-by-state guide to the state of regulations, taxation and market opportunities
- Annual survey of cannabis businesses
- Consumer understanding
- And more!
That announcement, which is said to be coming in a big order, failed to make things go as usual on Monday.
Several people with knowledge of the cannabis office discussion involving cannabis industry figures, the President, top lawmakers and Cabinet officials said an announcement could come as soon as Wednesday.
Chris Roberts can be reached at chris.robert@mjbizdaily.com.
